Purpose 1-phenyl piperazine (PPZ) emerged from a Caco-2 monolayer screen as having high enhancement potential due to a capacity to increase permeation without significant toxicity. Our aim was to further explore the efficacy and toxicity of PPZ in rat ileal and colonic mucosae in order to assess its true translation potential. Methods Intestinal mucosae were mounted in Ussing chambers and apparent permeability coefficient (Papp) values of [
) was identified as a potentially efficacious epithelial permeability enhancer with low cytotoxicity in a Caco-2 monolayer screening study of 51 putative agents (1) . Compared to other enhancers, 0.1% PPZ had the highest overall potential (0.86/1.00) using apparent permeability coefficients (Papp) achieved with [ 3 H]-mannitol and 70 kDa dextran across Caco-2 monolayers. PPZ (0.1%) showed one of the largest decreases in monolayer TEER normalized to that of 1% Triton®-X-100, while at the same time it had little effect on MTT production, indirect evidence of a high enhancement potential in vitro. Moreover, fluorescent microscopy images suggested that 0.1% PPZ promoted the paracellular pathway, as indicated by calcein measurements in Caco-2 cells (2) . A recent study (3) further tested the mechanism of action of 13 PPZ-related derivatives andconcluded that an apical side buffer pH of 8.7-9.6 was conferred by piperazine enhancers in Caco-2 monolayer studies, suggesting a role for pHdependent molecular parameters. To our knowledge however, no study has further examined whether PPZ enhances permeation in less reductionist intestinal tissue models, nor what the mechanism of stimulating paracellular flux increase might be. Designation of Bnon-toxic^to an agent on the basis of two cytotoxicity assays in Caco-2 cells might be somewhat premature, as the MTT and LDH release assays have limitations and there is limited predictive correlation between cytotoxicity data seen in Caco-2 cells and that of less reductionist models, or indeed with in vivo. Moreover, piperazine structures are associated with active pharmacology: piperazine citrate was developed in the 1950s as a treatment for roundworm and threadworm infections, by inducing paralysis via GABA receptor antagonism (4) . PPZ and piperazine derivatives are also ligands for dopamine (D 2 )-like, 5-HT 1A and 5-HT 4 receptors (5,6); some exhibit antidepressant properties by inhibiting neurokinin receptors (7) , while others are also used in the treatment of schizophrenia (8) and motion sickness (9) . Up to 10 mg of 5-HT is stored in enterochromaffin cells in the human intestine, accounting for 60-90% of the overall 5-HT in the body (10) , and when stimulated, the EC cells release 5-HT to activate receptors on adjoining nerves (11). 5-HT impacts gastrointestinal motility (12) , colonic transit (13) and enterocyte epithelial electrogenic ion secretion (14) . After stimulation, epithelial cells and platelets reabsorb 5-HT from the interstitial space through the serotonin-selective reuptake transporter (SSRT) at the base of crypts or in the basement membrane (15) , thereby removing luminal 5-HT to dampen further mucosal effects (16) . It causes an increase in short circuit current (Isc) via 5-HT 4 receptor activation in rat colonic mucosae with an EC 50 of 4 μM (17,18), so these receptors are functional in isolated tissue mucosae and may respond to low concentrations of agonists including piperazines, a pathway that cannot accurately be probed in Caco-2 monolayers due to variable receptor expression and unreliable Isc responses. Therefore, the extensive pharmacology of piperazines if demonstrated in relevant intestinal models, could mitigate against their development as oral permeability enhancers. On the other hand, diketofumaryl piperazine (DKFP), another piperazine derivative, is a solubilizing non-active excipient in MannKind Corporation's Technosphere™ dry powder delivery system, which was approved in 2014 for pulmonary delivery of insulin to Type I and II diabetics (Afrezza®) (19) . There has been no data published to suggest that DKFP has active pharmacology in the lung, whatever about the intestine.
The study aims were to therefore to determine whether PPZ might increase paracellular permeability in noncytotoxic fashion across isolated rat intestinal mucosae mounted in Ussing chambers, and also to verify if the Caco-2 monolayer screening of this putative enhancer was predictive. Secondly, we investigated whether myosin light chain kinase inhibitors and 5-HT 4 antagonists could inhibit PPZinduced permeability across Caco-2 monolayers and rat intestinal tissue mucosae. We confirmed that PPZ increases paracellular flux in concentration-dependent fashion across rat intestinal mucosae, and that selected enhancing concentrations are indeed non-cytotoxic, but suggest that the mechanism of action at the tight junction is multi-factorial, highly complex, and involves epithelial 5-HT receptor activation.
MATERIALS AND METHODS

Intestinal Tissue Preparation for Ussing Chamber Studies
Studies carried out were in accordance with the UCD Animal Research Ethics Committee protocol, AREC-14-28 Brayden, and were in adherence with the BPrinciples of Laboratory Animal Care,^(NIH Publication #85-23, revised in 1985). Male Wistar rats (250-300 g; Charles River, UK) were housed in the Biomedical Facility in University College Dublin (UCD) under controlled environmental conditions with 12:12 light: dark cycles, as well as with access to tap water and standard laboratory chow ad lib. Rats were euthanized by stunning followed by cervical dislocation. Ileal or colonic mucosae were removed and placed into freshly oxygenated Krebs-Henseleit buffer (KH). Excised intestinal epithelial tissue with intact lamina propria was dissected free of underlying smooth muscle according to previous descriptions (e.g. (20) ). Mucosae were pinned between pre-equilibrated Ussing chamber halves (World Precision Instruments, WPI, UK) with circular diameters of 0.63 cm 2 . 5 mL KH was added bilaterally and chamber fluids were oxygenated using a gas-lift system with 95% O 2 /5% CO 2 at 37°C. Each chamber half had voltage and current electrodes connected to a voltage clamp apparatus (EVC4000; WPI, UK) via a pre-amplifier. Silver/silver chloride (Ag/AgCl) electrodes were prepared by heating 3 M KCl with 3% agar and cooled in plastic casing. The potential difference (PD; mV) was measured across the mucosa in an open circuit configuration. When the voltage was clamped to 0 mV, the short circuit current (Isc; μA/cm 2 ) was determined and transepithelial electrical resistance (TEER; Ω.cm 
Effect of PPZ on cAMP Levels in Caco-2 Cells and Colonic Mucosae
When Caco-2 reached 70-80% confluence, they were trypsinized with trypsin-EDTA (1X; Gibco, Ireland) and seeded onto collagen (5 μg/cm 2 ) coated 24-well plates at a density 1 × 10 x6 cells/mL. On day 3, cells were washed with serum free media (SFM) and then incubated with fresh SFM, supplemented with 1 mM of the phosphodiesterase inhibitor, 3-isobutyl-1-methyl-xanthine (IBMX, Calbiochem) in a humidified incubator with 95% O 2 /5% CO 2 , at 37°C for 60 min. PPZ (0.6-60 mM) or the adenylate cyclase activator, forskolin (FSK, 10 μM) were then added for 15 min and then aspirated. The cells were trypsinized and DMEM was added to inactivate the trypsin. The cells were then centrifuged at 10,000 rpm for 10 min and washed 3 times with cold PBS. The pellet was resuspended in cell lysis buffer 5 (1x) at a concentration 1 × 10 7 cells/mL and stored at −20°C. A freeze/thaw cycle was performed to ensure total cell lysis. The lysate was then centrifuged at 600×g for 10 min at 4°C to remove cellular debris and the supernatant was stored at −20°C. Rat colonic mucosae were also equilibrated for 45 min before the basolateral addition of PPZ (0.6-60 mM) and FSK (10 μM) treatments in the presence of IBMX (1 mM). After 15 min, the mucosae were removed from the chamber and snap-frozen in liquid nitrogen. The tissue was homogenized in cell lysis buffer 5 (1x) and stored at −20°C. A freeze/thaw cycle was performed before being centrifuged at 600×g for 10 min at 4°C and stored at −20°C. The supernatants from Caco-2 cells and tissue mucosae were tested for the capacity to induce cAMP production in duplicate following the manufacturer's instructions (Parameter™ cAMP assay; Catalogue number KGE002; R&D Systems) (24) .
Cytotoxicity Assay in Caco-2 Cells and Intestinal Mucosae
The viability of Caco-2 cells treated with PPZ was determined by the MTT assay (25) . Cells were seeded at a density of 1 × 10 5 cells/mL in 96-well plates for 24 h. Fresh DMEM was applied and allowed to equilibrate before PPZ (60 μM-60 mM) or Triton® X-100 (0.1% v/v) were added. Plates were then placed into a humidified incubator with 95% O 2 / 5% CO 2 , at 37°C for 1 h or 24 h exposure. The LDH assay was also carried out for PPZ-treated rat mucosae as previously described (26) . Ileal and colonic mucosae were mounted in Ussing chambers for 120 min and samples of apical bathing solution (200 μL) was removed at 0, 60 and 120 min and replaced with fresh KH. Samples were mixed with 200 μL TOX-7 for 30 min and assayed.
Confocal and Light Microscopy
Filter-grown Caco-2 monolayers were treated with PPZ (0.6 mM) for 20 min, washed 3 times with (PBS and fixed with paraformaldehyde (4% w/v) in PBS for 20 min. The monolayers were then washed 3 times with PBS and permeabilized with Triton® X-100 (0.1% v/v) in 5% w/v normal goat serum (NGS) in PBS for 60 min. After an additional 3 washes with PBS, monolayers were stained with primary antibody of mouse anti-claudin-2 (1:200; Zymed Laboratories, USA) in 5% NGS for 60 min, before being washed a further 3 times with PBS. The monolayers were stained with a secondary antibody of Alexa Fluor ® 568 anti-mouse IgG (1:200; Zymed Laboratories) and FITC-phalloidin in 5% NGS for 60 min before being washed 3 times with PBS and incubated with 4',6-diamidino-2-phenylindole (DAPI; 1:10,000) for 10 min. The monolayers were washed with fresh PBS to remove any extra stain. The monolayers were then excised from inserts and mounted onto glass slides with Vectrashield ® mounting medium (Vector Laboratories Ltd., UK) and the edges were sealed with clear nail varnish and stored at −20°C. Confocal microscopy was preformed on a Zeiss LSM 510 Meta using LSM5 acquisition software (Carl Zeiss Inc.) with a 543 nm filter (rhodamine), a 488 nm filter (FITC) and a 364 nm filter (DAPI). For light microscopy, rat ileal and rat colonic mucosae were treated apically with PPZ (0.6-60 mM) for 120 min. Mucosae was removed from the chambers and placed into 10% v/v buffered formalin and then embedded in paraffin wax. Tissue sections were mounted on adhesive coated slides, and stained with H&E. The slides were visualized under a light microscope (Labophot-2A; Nikon, Japan) and images taken with a high-resolution camera (Micropublisher 3.3 RTV; QImaging, Canada) and ImagePro ® Plus version 6.3 (Media Cybernetics Inc., USA) acquisition software.
Statistical Analysis
Statistical analysis was carried out using Prism-5 ® software (GraphPad®, USA). Unpaired Student's t-tests and ANOVA were used for single and group comparisons respectively. Results are given as mean ± SEM. A significant difference was deemed present if P < 0.05. (Fig. 3a, b) , accompanied by concentrationdependent reductions in TEER in both tissue types (Fig. 3c, d) . Thus, an inverse relationship was present between the increased fluxes of the paracellular markers and reduction in TEER values in monolayers, as well as across ileal, and distal colonic mucosae.
RESULTS AND DISCUSSION
Apically-added PPZ at a lower concentration of 0.6 mM caused an increase in the Papp for both flux markers in rat distal distal colon, but only for FD-4 in rat ileum (Fig. 3a) . Importantly, PPZ (0.6 mM) caused an 8-fold increase in Papp of [
14 C]-mannitol across distal colonic mucosae, but was without effect on the Papp across proximal colonic mucosae (P < 0.001), so all colonic studies within refer to the former. While basolateral addition of PPZ (0.6-6 mM) had no effect on the [
14 C]-mannitol Papp across ileal or colonic mucosae, a concentration of 60 mM added to that side increased the Papp, but this was associated with histological damage (data not shown). To test recovery of monolayers exposed to 0.6-60 mM PPZ, the apical reservoir buffer containing PPZ were replaced with with KH and the TEER recovered over 24 h for 0.6 and 6 mM, but not for 60 mM. (Fig. 4) . In parallel studies in colonic tissue, apical side additions of PPZ again reduced TEER over 20 min and, following incubation in fresh KH for 2 h, TEER partially recovered to 80% maximum TEER (versus 35%, without wash-out) and 75% maximum TEER (versus 30%, without washout) in the respective cases of 0.6 and 6 mM, but not at all to 60 mM where it remained at just 10% maximum TEER throughout irrespective of wash-out (n = 4 each group, data not shown).
PPZ Activates Apical 5-HT 4 Receptors and Increases Intracellular cAMP
It was hypothesized that the mechanism of action of PPZ in enhancing paracellular permeability in intestinal epithelial in vitro models was via an action at 5-HT 4 receptors in plasma membranes of Caco-2 monolayers (32) and intestinal epithelia (33) . Bilateral pretreatment of monolayers for 20 min with the selective 5-HT 4 antagonists, SB-204070 (10 μM) and GR11808 (1 μM) caused a reduction in PPZ (0.6 mM)-induced increase in the Papp of [ 14 C]-mannitol (Fig. 5a) . At higher concentrations of PPZ (6-60 mM) however, SB-204070 had no effect. In contrast, GR11808 reduced the PPZ (6-60 mM)-induced permeability at these higher PPZ concentrations, although Papp values were still higher than those for untreated monolayers (data not shown). In rat distal colonic mucosae, pretreatment with bilateral SB-204070 and GR11808) also caused a reduction in PPZ (0.6, 6 and 60 mM)-induced Papp of [14C]-mannitol (Fig. 5b) . Due to limited availabilities of 5-HT 4 antagonists, these experiments were not repeated in rat ileal mucosae. These data suggest that PPZ opens tight junctions in part by activation of 5-HT 4 receptors on the apical membranes of both monolayers and colonic tissue.
Intracellular cAMP concentrations in Caco-2 cells after 15 min exposure to PPZ (60 μM-60 mM) were increased (Fig. 6a) , although levels were lower than the maximal effects stimulated by the positive control, FSK (10 μM). Basal cAMP levels were 26.3 ± 1.8 (n = 4) and 20.5 ± 0.9 pmol/mg (n = 4) for Caco-2 cells and rat colonic mucosae, respectively. Fig. 4 TEER recovery in Caco-2 monolayers following 2 h exposure to PPZ at time zero, subsequent wash-out, and incubation in fresh buffer over 24 h in DMEM. ***P < 0.001, compared to untreated controls at 2 h; ***P < 0.001, for monolayers treated with 60 mM PPZ compared to untreated controls at 24 h (n = 4). C]-mannitol. 20 min pre-treatment with SB-204070 (SB; 10 μM) and GR11808 (GR; 1 μM) followed by PPZ. (a) Caco-2 monolayers: *** P < 0.01 comparing 0.6 mM PPZ in the presence and absence of inhibitors, and also for PPZ versus untreated controls (b) rat colonic mucosae: *P < 0.05; compared to PPZ at three respective concentrations without antagonists; **P < 0.01 for PPZ compared to untreated controls (n = 4-12).
Basolateral addition of FSK (10 μM) caused a maximal increase in intracellular cAMP after 15 min in both Caco-2 and colonic mucosae, Δ 26.1 ± 0.9 (n = 4) and Δ 21.4 ± 0.5 pmol/mg (n = 4), respectively. In rat colonic mucosae, apical addition of PPZ (6-60 mM) also caused increases in intracellular cAMP after 15 min exposure (Fig. 6b) . Agents including FSK elevate intracellular cAMP and are well-known to induce electrogenic Cl − and H 2 O secretion across intestinal tissue mucosae, increasing epithelial tight junction permeability in parallel (34) . We confirmed that apical addition of PPZ caused concentration-dependent increases in Isc across colonic mucosae in the concentration range that enabled increased flux of paracellular markers and reductions in TEER (Fig. 6c) ; effects from apical addition were more efficacious than basolateral, confirming the importance of apical side presentation to 5HT 4 -and possibly other receptors. Furthermore, 20 min pre-treatment with the loop diuretic and inhibitor of the basolateral Na/K/2Cl cotransporter, bumetanide (100 μM), followed apical PPZ (0.6-60 mM) reduced the capacity of PPZ to stimulate the Papp of [ 14 C]-mannitol across rat distal colonic mucosae over 120 min (Table I) . Therefore this data suggests that PPZ may activate 5HT 4 G-protein coupled receptors, which in turn regulates the Na/K/2Cl cotransporter via adenylate cyclase mediated production of cAMP ultimately to stimulate electrogenic chloride secretion and to open intestinal epithelial tight junctions.
PPZ Paracellular Transport is Facilitated by MLCK in Monolayers and Colonic Mucosae
The mechanism of action by which PPZ increased permeability across intestinal tissue may involve multiple pathways, therefore several inhibitors were used to examine regulated enzymes pertaining to tight junction opening. ML9 is a reversible competitive inhibitor of MLCK (K i : 3. Fig. 6 Release of cAMP (expressed as % maximum) of PPZ-treated (0.6-60 mM) (a) Caco-2 cells and (b) rat distal colonic mucosae for 20 min, compared to FSK (10 μM) control. *P < 0.05; **P < 0.01; ***P < 0.001 (n = 4 each group). (c) PPZ increased Isc across colonic mucosae predominantly from the apical side (n = 3 for each concentration). (Fig. 7a) and rat distal colonic mucosae (Fig 7b) . Therefore it appears that MLCK is involved in the intracellular mechanism of PPZ-induced tight junction openings.
PPZ Effects Expression of F-actin and claudin-2 in Caco-2 Monolayer Tight Junctions
Confluent monolayers stained with F-actin showed a typical Bchicken wire^conformation around the periphery of each cell (Fig. 8a) . Apical addition of PPZ (0.6 mM) for 20 min caused a decrease in F-actin staining around the cell and an increase staining of G-actin in the cytoplasm (Fig. 8b) . Monolayers stained with claudin-2 antibodies showed little or no expression in untreated monolayers (Fig. 8c) . Following PPZ (0.6 mM) addition however, increased claudin-2 expression was observed between treated cells (Fig. 8, d ), indicative of increase paracellular permeability (36) . This suggests that PPZ alters tight junction protein expression as well as F-actin localization in treated monolayers at concentrations known to increase paracellular permeability.
Concentration-Dependent Toxicity of PPZ In Vitro and Ex Vivo: MTT, LDH and Histology
The MTT assay was used to examine both acute (1 h) and chronic (24 h) exposure to PPZ in Caco-2 cells. There was a significant reduction in cell viability when PPZ (6-60 mM) was added to Caco-2 cells for these time periods (Fig. 9a, b) . However, this decrease was much less than damage caused by the addition of Triton® X-100 (0.1% v/v). Nevertheless, after 60 min of PPZ (6 mM) exposure, the majority of cells were still viable (73.7 ± 5.1%), but this decreased to almost half after 24 h (57.5 ± 9.5%). PPZ (up to 0.6 mM) however was relatively non-cytotoxic to Caco-2 cells up to 24 h, the same concentration that could enhance flux of paracellular flux markers. In rat ileal (Fig. 9c) and colonic (Fig. 9d ) mucosae mounted in Ussing chambers for 120 min, there was no increase in LDH release at concentrations of PPZ of 0.6-6 mM, however 60 mM PPZ induced LDH release comparable to Triton® X 100, suggesting a toxic effect at this concentration. Light microscopy of rat ileal and colonic mucosae exposed to PPZ for 120 min was examined using H&E staining (Fig. 10) . There was an increase in epithelial cell damage with high concentrations of PPZ (6 mM) (Fig. 10 c, f) compared to lower concentration of 0.6 mM (Fig. 10 b, e) in both ileal and colonic mucosae. Lower concentrations of PPZ (0.6 mM) induced little damage in either ileal or colonic tissue compared to controls ( Fig. 10 a, d ).
SUMMARY AND CONCLUSIONS
Previous work using Caco-2 cells indicated that PPZ was in the top tier of a screen of molecules that displayed high permeation enhancer efficacy and low cytotoxicity (1,2) with direct evidence for induced tight junction openings (2) . Here, we confirmed and expanded on some of these data using isolated rat intestinal tissue mucosae and provide further insight into the mechanism of action of PPZ on intestinal epithelia, as well as information on its pharmacology and toxicology. Firstly, PPZ induced flux of several paracellular flux markers across Caco-2 monolayers and rat ileal and distal colonic mucosae models. Secondly, by comparing PPZ to other permeation enhancers also tested in isolated rat intestinal tissue mucosae, we can conclude that its efficacy is on a par with some of the gold standard enhancers in clinical trials including C 10 , and palmitoyl carnitines, both thought to act in part by opening tight junctions via intracellular-mediated mechanisms, driven by initial plasma membrane perturbation and fluidization (reviewed in (37)). A combination of MTT assay in Caco-2 cells, LDH release from intestinal tissue, reversibility of TEER reductions upon PPZ removal in monolayers and tissue mucosae, and histology of mucosal sheets following PPZ exposure suggested that concentrations up to 6 mM were non-toxic in these bioassays. As with medium chain fatty acid salts, there is a concentration window in which PPZ induces increased paracellular flux without significantly damaging cells and tissues. Recently, Lamson et al. (3) , examined a set of hydrocarbon-substituted piperazine derivatives as permeation enhancers in Caco-2 monolayers and an important factor was that effective non-cytotoxic ones altered the apical-side HBSS pH to 9.2-9.6, thereby causing permeability enhancement beyond what was expected from pH changes Fig. 11 Cartoon of likely mechanism of action of PPZ in intestinal tissue mucosae. Na/K/2Cl is the cotransporter and CFTR is the cystic fibrosis transmembrane regulator. Activation of the combination of two transporters by PPZ-stimulation of intracellular cAMP via apical 5HT 4 receptors gives rise to an increase in electrogenic chloride secretion (increase in Isc) and tight junction (TJ) opening in parallel. Indirect Na/K/2Cl activation by PPZ also leads to tight junction opening since the effects of PPZ on paracellular flux were inhibited by bumetanide. Piperazine structures also induce an alkaline pH in the apical buffer, which may impact on permeability (3).
alone. Alkaline pH induction of the apical-side buffer, at least in vitro, appears therefore to contribute in part to the tight junction-opening effects of piperazine-related structures. Examination of the true translational potential of any putative candidate also involves study of its intestinal pharmacology, which ideally should be minimal. It was hypothesized that the specific mechanism of action of PPZ in enhancing paracellular permeability might be through 5-HT 4 receptors present on the apical membrane of Caco-2 cells and intestinal epithelia. Apical addition of PPZ activated 5-HT 4 receptors in monolayers and tissue mucosae (inhibited in part by two antagonists) resulting in a cascade of events. These included an increase in intracellular cAMP, stimulation of the MLC pathway, activation of the basolateral Na/K/2Cl cotransporter, ultimately leading to an increase in transepithelial electrogenic chloride secretion (i.e. Isc increase) linked to tight junction modulation (i.e. bumetanide-sensitivity). A cartoon is provided to summarize these pathways (Fig. 11 ). In conclusion, the clinical use of PPZ as a potential oral drug permeation enhancer is therefore likely to be limited by its multiple mechanisms on intestinal epithelial ion transport function, as well as by its interaction with the physiologically-important enteric 5-HT system.
